Search - tctmd.com

Displaying 201 - 214 of 214

Sort: Relevancy | Date

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

CME

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

Defining Cost-Effectiveness and Quality of Life for TAVR

CME

Defining Cost-Effectiveness and Quality of Life for TAVR

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

CME

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

Partner Content

CME Landing Page

November 22, 2016

Partner Content

CME Credit: The Latest Data on Expanded Indications and What it Means for Referring Cardiologists

November 17, 2016

Changing Course with Anticoagulation in Secondary Prevention of CAD

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

CME

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

Video

»

Aspirin Variability Interactions and Formulations

February 24, 2020

PLX Pharma - Aspirin for the Interventionalist: More Than Meets the Eye

CME

Aspirin for the Interventionalist: More Than Meets the Eye

Aortic Stenosis, TAVR, ViV-TAVR: Peri-procedural Hemodynamics

CME

Aortic Stenosis, TAVR, ViV-TAVR: Peri-procedural Hemodynamics

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Partner Content

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

November 16, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.